Steinfeldt, Jakob
Wild, Benjamin https://orcid.org/0000-0002-7492-8448
Buergel, Thore
Pietzner, Maik https://orcid.org/0000-0003-3437-9963
Upmeier zu Belzen, Julius https://orcid.org/0000-0002-0966-4458
Vauvelle, Andre
Hegselmann, Stefan
Denaxas, Spiros
Hemingway, Harry https://orcid.org/0000-0003-2279-0624
Langenberg, Claudia https://orcid.org/0000-0002-5017-7344
Landmesser, Ulf
Deanfield, John
Eils, Roland https://orcid.org/0000-0002-0034-4036
Article History
Received: 14 August 2024
Accepted: 2 January 2025
First Online: 10 January 2025
Change Date: 10 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-56429-1
Competing interests
: U.L. received research grants to the institution from Abbott, Amgen, Bayer and Novartis. J.D. received honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk, Bayer, and is a Trustee of Our Future Health. R.E. received honoraria from Sanofi and consulting fees from Boehringer Ingelheim. All other authors do declare no competing interests.